Adaptive Biotechnologies Corp — Form 4
Filed July 23, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 59/100
What the filing says
Chief Scientific Officer ROBINS HARLAN S (ADPT) sold 777K shares (~$10.8M) on the open market (49% of holdings). Large sale — ~49% of holdings.
Why this rating
Large sale — ~49% of holdings.
See more from July 23, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.